Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts.

Publication Date: 2024 Jun 03


Full Text Sources

Ovid Technologies, Inc.

PubMed Central (Free)

Europe PubMed Central (Free)

Silverchair Information Systems (Free)

Related Articles


Authors

Erikka Loftfield; Caitlin P O'Connell; Christian C Abnet; Barry I Graubard; Linda M Liao; Laura E Beane Freeman; Jonathan N Hofmann; Neal D Freedman; Rashmi Sinha

Abstract

OBJECTIVE

One in 3 US adults uses multivitamins (MV), with a primary motivation being disease prevention. In 2022, the US Preventive Services Task Force reviewed data on MV supplementation and mortality from randomized clinical trials and found insufficient evidence for determining benefits or harms owing, in part, to limited follow-up time and external validity.


Source

JAMA network open


Pub Types(s)

Journal Article


Language

English


PubMed ID

38922615